Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Syncytin-2 (human endogenous retrovirus group FRD member 1 envelope protein, HERV-FRD Env) (Syncytin-2 (or HERV-FRD Env))
- Target
- Syncytin-2 (or HERV-FRD Env)
- Molecular classification
- Endogenous retroviral envelope protein, Viral fusion protein, Other (non-receptor, non-enzyme, non-channel, non-transcription factor)
01
Overview
Syncytin-2, encoded by the HERV-FRD provirus ancestral env polyprotein gene, is an envelope protein of endogenous retroviral origin expressed in human placenta. Unlike most retroviral envelopes, syncytin-2 mediates cell–cell fusion in the placenta, playing a crucial role in the formation of the syncytiotrophoblast, which is essential for fetomaternal nutrient exchange[2][3]. The gene is uniquely expressed in placental tissue and is highly conserved among simians[2]. Unlike some other HERV env proteins, syncytin-2 does not appear to play a role in viral infection or classical signaling, and is not a receptor, transporter, or classical therapeutic target. No drug interactions or known safety concerns are linked to this gene.
- Other names
- HERV-FRD EnvSyncytin-2Endogenous retrovirus group FRD member 1 envelope protein
02
Biological functions
Placenta formation: Induces cell–cell fusion in the developing human placenta[2][3].Syncytiotrophoblast formation: Drives the formation of the multinucleated outer layer of the placenta, essential for maternal-fetal interface[2].
03
Disease associations
Other (not linked to specific diseases, though research investigates HERVs for possible roles in cancer, autoimmunity, and placental pathologies. No direct, widely accepted causal connection for HERV-FRD/Syncytin-2)[1].
Beyond the preview
Go deeper on Syncytin-2 (human endogenous retrovirus group FRD member 1 envelope protein, HERV-FRD Env) (Syncytin-2 (or HERV-FRD Env)).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Syncytin-2 (human endogenous retrovirus group FRD member 1 envelope protein, HERV-FRD Env) (Syncytin-2 (or HERV-FRD Env)).